Sebastian Fucile

Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)

Oliver Kornmann, Jorge Máspero, Richard N. van Zyl-Smit et al. · Respiratory Medicine · 2020 · 78 citations

Asthma, Non-inferiority Study, Pharmacotherapy +6

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

Antonio Anzueto, C. Franz Vogelmeier, Κonstantinos Κostikas et al. · International Journal of COPD · 2017 · 44 citations · Full text

Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program

Ioanna Tsiligianni, Karen Mezzi, Sebastian Fucile et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2017 · 41 citations · Full text

Asthma, Advanced Lung Disease, Clinical Trials +10

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

Jadwiga A. Wedzicha, Dave Singh, Ioanna Tsiligianni et al. · Respiratory Research · 2019 · 24 citations · Full text

Pulmonary exacerbations in insured patients with bronchiectasis over 2 years

Patrick A. Flume, Joseph Feliciano, Matthew Lucci et al. · ERJ Open Research · 2023 · 11 citations · Full text